Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released from enteroendocrine cells in response to nutrient ingestion and act on receptors in the pancreas, gastrointestinal tract, and central nervous system to regulate appetite, insulin secretion, and energy metabolism
Cost considerations and practical planning Peptide protocols for disc herniations are not covered by insurance, and costs can add up over multi-week protocols
A few minutes on your goals, then a quick call with a US-licensed provider
DAMPs in the immunogenicity of cell death
This compounded therapy combines both peptides to deliver synergistic healing and recovery effects that neither peptide achieves alone
Philadelphia: Lippincott, Williams & Wilkins